Elevance Execs Dish on ACA Exchange, Commercial Segment Strategies

Although improving Medicare Advantage margins has been the hottest topic recently in managed care, executives at Elevance Health, Inc. at a recent investor conference made some noteworthy comments about the firm’s commercial and Affordable Care Act exchange businesses — both of which insurers are talking more glowingly about amid government-business headwinds.

Regarding the company’s ACA exchange business, “we certainly aren’t looking for membership over margin,” Morgan Kendrick, president for the insurers commercial and specialty health benefits segment, said during a June 12 question-and-answer session at the Goldman Sachs Global Healthcare Conference.

0 Comments
© 2024 MMIT
Leslie Small

Leslie Small

Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

Related Posts

centene-under-microscope
June 7

Under Pressure? Insurers Hustle to Prove Medicaid Biz Isn’t Struggling

READ MORE
capitol-hill
June 13

At Investor Conferences, Execs Paint PBM Reform as Afterthought

READ MORE
us-capitol
May 24

Possible Marketplace Tax Credit Extension Raises Republican Hackles

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today